GEXVal CEO Delivers Lecture at Kindai University*

株式會社 GEXVal
2024年6月29日 

GEXVal CEO Delivers Lecture at Kindai University*

Juran Kato, PhD, President and CEO of GEXVal Inc., was appointed as a part-time lecturer at Kindai University and delivered a special lecture at the Faculty of Pharmacy on the Higashi Osaka Campus on June 29, 2024. The lecture was held as part of the "Special Lecture 1" and "Advanced Special Lecture 1" courses for the Graduate School of Pharmacy at Kindai University, with approximately 150 graduate students and faculty members in attendance.

Dr. Kato's lecture focused on the theme "Purposed to Repurpose® - How to Deliver Innovative Medicines to Patients with Rare Diseases" She addressed the issues of “access to medicine” among patients with rare diseases, and GEXVal’s initiatives to address these challenges. Dr. Kato highlighted GEXVal’s unique AI-assisted innovation engine, RePhaINDTM, and drug discovery approach. Additionally, she touched upon potential career paths for researchers in this field.

Following the lecture, attendees expressed increased interest in the development of new drugs for rare diseases and the role of venture companies. Through this special lecture, Dr. Kato provided the next generation of researchers with exposure to new career opportunity to consider the future of drug development in Japan.

*Kindai University is one of Japan's largest and most innovative private universities. Renowned for its cutting-edge research and high number of applicants, Kindai University has been at the forefront of technological advancements and industry collaborations. The university is particularly famous for its success in fully farm-raising bluefin tuna, a world-first achievement that exemplifies its commitment to sustainable innovation.

有關本事宜請諮詢:
Head of Corporate office
Atsushi Sugizaki
info@gexval.com